Skip to Content
The Center for Health Promotion and Prevention Research

Adolescent Vaccination Program

Banner image for Adolescent Vaccination Program

The Adolescent Vaccination Program (AVP) is a multicomponent HPV vaccination program that targets healthcare providers and parents of pediatric patients ages 11-17. It was developed by researchers and physicians at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health and Baylor College of Medicine. The AVP contains a suite of evidence-based strategies to increase vaccination, including immunization champions, provider assessment and feedback, provider reminders, provider continuing education, patient reminder and recall systems, and patient (parent) education. The AVP was implemented in a large urban pediatric clinic network in Houston, Texas from November 2015 to February 2019, and it is currently being implemented in a clinic network in San Antonio, Texas. Results indicate that the AVP is feasible for clinic use and effective in increasing both initiation and completion of the HPV vaccine series among male and female patients. As a result, an Adolescent Vaccination Program Implementation Tool (AVP-IT) is currently in development to assist other clinics in Texas to roll out these evidence-based strategies.

The following grants have been funded by the Cancer Prevention & Research Institute of Texas (CPRIT) as a result of the Adolescent Vaccination Program:

  • Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics (PP140183)
  • Multi-component Interventions for Patients and Providers to Increase HPV Vaccination in a Network of Pediatric Clinics in Houston, TX (RP150014)
  • Adolescent Vaccination Program (AVP): Expanding a Successful Clinic-based Multicomponent HPV Vaccination Program to the San Antonio Area (PP180089)
  • Adolescent Vaccination Program: Online Decision Support for Adoption of Evidence-based HPV Vaccination Strategies by Texas Pediatric Clinics (PP190041)

People

Dr. Sally Vernon, Principal Investigator